These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Qinhuo Shanggan oral solution resolves acute lung injury by down-regulating TLR4/NF-κB signaling cascade and inhibiting NLRP3 inflammasome activation. Tang S, Liang Y, Wang M, Lei J, Peng Y, Tao Q, Ming T, Yang W, Zhang C, Guo J, Xu H. Front Immunol; 2023 Sep; 14():1285550. PubMed ID: 37954597 [Abstract] [Full Text] [Related]
13. The involvement of oxidative stress and the TLR4/NF-κB/NLRP3 pathway in acute lung injury induced by high-altitude hypoxia. Cao W, Zeng Y, Su Y, Gong H, He J, Liu Y, Li C. Immunobiology; 2024 May 20; 229(3):152809. PubMed ID: 38788361 [Abstract] [Full Text] [Related]
14. MicroRNA-27a alleviates LPS-induced acute lung injury in mice via inhibiting inflammation and apoptosis through modulating TLR4/MyD88/NF-κB pathway. Ju M, Liu B, He H, Gu Z, Liu Y, Su Y, Zhu D, Cang J, Luo Z. Cell Cycle; 2018 May 20; 17(16):2001-2018. PubMed ID: 30231673 [Abstract] [Full Text] [Related]
15. Anti-inflammatory effect of Yam Glycoprotein on lipopolysaccharide-induced acute lung injury via the NLRP3 and NF-κB/TLR4 signaling pathway. Niu X, Zang L, Li W, Xiao X, Yu J, Yao Q, Zhao J, Ye Z, Hu Z, Li W. Int Immunopharmacol; 2020 Apr 20; 81():106024. PubMed ID: 31784404 [Abstract] [Full Text] [Related]
16. Aloin suppresses lipopolysaccharide-induced acute lung injury by inhibiting NLRP3/NF-κB via activation of SIRT1 in mice. Lei J, Shen Y, Xv G, Di Z, Li Y, Li G. Immunopharmacol Immunotoxicol; 2020 Aug 20; 42(4):306-313. PubMed ID: 32419528 [Abstract] [Full Text] [Related]